Carvedilol-Enriched Cold Oxygenated Blood Cardioplegia Improves Left Ventricular Diastolic Function After Weaning

Geir Olav Dahle1, Pirjo-Riitta Salminen2, Christian Arvei Moen3

  • 1Section of Cardiothoracic Surgery, Department of Heart Disease, Haukeland University Hospital, Bergen, Norway;; Department of Clinical Science, University of Bergen, Bergen, Norway;.

Insights

Adding carvedilol to blood cardioplegia improved diastolic cardiac function and reduced oxidative stress in pigs after bypass. This antioxidant agent enhanced myocardial recovery following cardioplegic arrest.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Pharmacology

Background:

  • Myocardial protection during cardiac surgery is crucial for patient outcomes.
  • Oxygenated blood cardioplegia is a standard method for inducing cardiac arrest.
  • Carvedilol possesses antioxidant properties and receptor-blocking activity that may benefit myocardial function.

Purpose of the Study:

  • To evaluate the efficacy of adding carvedilol to oxygenated blood cardioplegia.
  • To determine if carvedilol improves myocardial function after weaning from cardiopulmonary bypass.
  • To assess the impact of carvedilol on myocardial oxidative stress.

Main Methods:

  • A randomized controlled study was conducted in a university laboratory setting.
  • Twenty anesthetized pigs underwent cardiopulmonary bypass with cold, oxygenated blood cardioplegia containing either carvedilol or a vehicle.
  • Cardiac arrest was maintained for 100 minutes, followed by reperfusion and assessment of left ventricular function using pressure-volume loops and strain analysis.

Main Results:

  • Carvedilol significantly improved left ventricular diastolic compliance and relaxation.
  • Diastolic relaxation constant (τ) and dP/dtmin were significantly improved in the carvedilol group.
  • Myocardial oxidative stress, indicated by malondialdehyde levels, was significantly reduced by carvedilol treatment.
  • No significant differences were observed in systolic function parameters between the groups.

Conclusions:

  • Carvedilol added to blood cardioplegia enhances diastolic cardiac function post-reperfusion.
  • Carvedilol effectively reduces myocardial oxidative stress in a porcine model.
  • The findings suggest a potential benefit of carvedilol in myocardial protection during cardiac surgery.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
414
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
731
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K